Maa: Irlanti
Kieli: englanti
Lähde: HPRA (Health Products Regulatory Authority)
LEVAMISOLE HYDROCHLORIDE, RAFOXANIDE
Biochem Ltd
QP52AE51
LEVAMISOLE HYDROCHLORIDE, RAFOXANIDE
Unknown
Oral Suspension
LM-Licensed Merchant
Bovine, Ovine
Levamisole, combinations
Endoparasiticide
Authorised
1999-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Levafluke Oral Drench. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION For a full list of excipients see section 6.1 3 PHARMACEUTICAL FORM Oral Suspension. A yellow aqueous suspension. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and sheep. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES _LEVAFLUKE _is a combination product for the treatment of the common nematode parasites (including lung worm - _Dicytocaulus _spp.) and liver fluke (_Fasciola hepatica_) in cattle and sheep. _Levafluke _is active against _Fasciola hepatica, (mature and immature over 8 weeks of age)_ _Nematodirus spp.,_ _Dictyocaulus spp.,_ _Ostertagia spp. _in cattle and sheep (except inhibited ostertagia larvae)_._ 4.3 CONTRAINDICATIONS Do not use in concurrent treatment with organophosphates and/or diethylcarbamazine. Do not use in animals with known hypersensitivity to the active ingredients. ACTIVE SUBSTANCE QUANTITY PER ML Rafoxanide 22.5 mg Levamisole Hydrochloride 15.0 mg EXCIPIENTS Methyl Parahydroxybenzoate (E218) 1.0 mg Propyl Parahydroxybenzoate (E216) 0.1 mg Sodium metabisulphite (E223) 0.2 mg Quinoline yellow (E104) 0.09 mg IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 16/04/2013_ _CRN 7014587_ _page number: 1_ 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result in ineffective therapy: - Too frequent and repeated use of anthelmintics from the same class, over an extended period of time. - Underdosing which may be due to underestimation of bodyweight, misadministration of the product, or lack of calibration of the dos Lue koko asiakirja